Leo Doumanian
Papers
6
Total Citations
211
H-Index
6
About
Dr. Leo Doumanian is a pioneering urologic surgeon whose research has fundamentally reshaped the surgical management of benign prostatic hyperplasia (BPH), particularly for patients with large prostates. His primary contributions center on the development and validation of Aquablation therapy, a minimally invasive, robotically-guided waterjet ablation technique. Dr. Doumanian led landmark clinical trials, including the pivotal WATER II study, demonstrating that Aquablation provides durable, long-term symptom relief for men with prostates 80-150 cc—a population traditionally requiring more invasive surgery. His work, cited over 200 times, established the procedure’s safety and efficacy, with 5-year results showing sustained improvements in urinary flow and quality of life while dramatically reducing the risk of irreversible sexual side effects like anejaculation compared to standard transurethral resection. Beyond BPH, Dr. Doumanian has advanced robotic techniques for complex reconstructive challenges, including robot-assisted ureteroneocystostomy for distal ureteral pathologies and the management of rectourethral fistulas following focal prostate cancer treatment. His research bridges the gap between technological innovation and patient-centered outcomes, making him a leading voice in the evolution of robotic urologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6